Cost-utility of 20-valent pneumococcal conjugate vaccine compared to no vaccination and recommended alternative vaccines among Belgian adults-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cost-utility of 20-valent pneumococcal conjugate vaccine compared to no vaccination and recommended alternative vaccines among Belgian adults

Published:2023-11-02 Issue:1 Volume:22 Page:1008-1021
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Marbaix Sophie¹²,Mignon Annick³,Taelman Audrey⁴,Averin Ahuva⁵,Atwood Mark⁵,Vietri Jeffrey⁶

Affiliation:

1. Health Economics, SNB management, Soignies, Belgium

2. Faculty of Medicine and Pharmacy, Research Institute for Health Sciences and Technology, University of Mons–UMONS, Mons, Belgium

3. Medical, Pfizer nv/sa, Brussels, Belgium

4. Health & Value, Pfizer nv/sa, Brussels, Belgium

5. Health Economics, Policy Analysis Inc. (PAI), Chestnut Hill, MA, USA

6. Patient & Health Impact, Pfizer Inc, Collegeville, PA, USA

Funder

Pfizer

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14760584.2023.2273892

Reference41 articles.

1. Burden of infections on older patients presenting to general practice: a registry-based study

2. Epidemiology and outcome of invasive pneumococcal disease among adults in Belgium, 2009–2011

3. Prognostic factors for mortality in invasive pneumococcal disease in adult: a system review and meta-analysis

4. Profile of hospitalised elderly patients in Belgium—Analysis of factors affecting hospital costs

5. The Intego database: background, methods and basic results of a Flemish general practice-based continuous morbidity registration project

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccination strategies for patients under monoclonal antibody and other biological treatments: an updated comprehensive review based on EMA authorizations to January 2024;Expert Review of Vaccines;2024-09-11

2. Pneumococcal vaccine uptake in patients with inflammatory arthritis: a single centre cohort study;Rheumatology;2024-06-04

3. Cost-effectiveness analysis of adult pneumococcal conjugate vaccines for pneumococcal disease in Japan;Expert Review of Vaccines;2024-05-09

4. Higher-valency pneumococcal conjugate vaccines in older adults, taking into account indirect effects from childhood vaccination: a cost-effectiveness study for the Netherlands;BMC Medicine;2024-02-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3